Clinical equipoise and placebo controls
- Topic
A trial is ethical if experts do not know which treatment is better; placebo is used only when it leaves no one without a proven treatment.
What it is
Clinical equipoise is the honest uncertainty of the expert community about which of the treatments being compared is better. If it exists, random assignment knowingly harms no one, and the trial is ethical. The concept was set out by Benjamin Freedman in 1987. Placebo is the hardest example: if an effective treatment already exists, giving placebo leaves one group without it. Helsinki and CIOMS allow it only under strict conditions, and Resolution 8430 classes placebo-controlled trials as greater than minimal risk.
Key facts
- Freedman distinguished the «theoretical» equipoise of a single investigator from the «clinical» equipoise of the medical community.
- The add-on design (placebo added to standard treatment) avoids leaving anyone without treatment.
- CIOMS, guideline 5: if an effective intervention exists, delaying or withholding it may add no more than a minor increase above minimal risk, with risks minimized.
- If an interim analysis breaks equipoise (one arm is clearly better or worse), the trial is stopped or modified.
In clinical practice
- Ethical: placebo for a mild, transient symptom with rescue available, or placebo added on to standard treatment.
- Unethical: placebo instead of effective treatment for a serious disease, when lack of treatment causes irreversible harm.
- The participant must know they may receive placebo and what rescue treatment exists.
- An independent data monitoring committee watches equipoise during the trial.
Legal framework in Colombia
- Resolution 8430 of 1993, art. 11, lit. c: randomized and placebo-controlled studies are greater than minimal risk, with written consent and committee approval.
- Resolution 8430, art. 7: when there are several groups, allocation is random and measures are taken to avoid risk or harm.
Test yourself
Think of the answer, then tap the question to see it.
What is clinical equipoise?
The genuine uncertainty of the expert community about which of the treatments compared in a trial is better; if it exists, randomization is ethical.
According to Helsinki, what should a new intervention be compared against?
The best proven intervention; placebo is the exception when no proven intervention exists or there are compelling methodological reasons without risk of serious harm.
What is an add-on placebo design?
Everyone receives standard treatment and, in addition, some receive the new drug and others placebo; no one is left without effective treatment.
Which risk category does a placebo-controlled trial have in Colombia?
Greater than minimal risk, under art. 11, literal c, of Resolution 8430 of 1993.
Connections
Educational content on ethics and health law; not legal advice. Laws and case law change: each page links the official text and says when it was last checked. For a real case, read the text in force and ask a lawyer or the medical ethics tribunal.
Sources: Equipoise and the ethics of clinical research (N Engl J Med 1987;317:141-5) (PubMed, National Library of Medicine, 1987); WMA Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Participants (World Medical Association, 2024); International Ethical Guidelines for Health-related Research Involving Humans (Council for International Organizations of Medical Sciences (CIOMS) and World Health Organization, 2016); Resolución 8430 de 1993: normas científicas, técnicas y administrativas para la investigación en salud (Ministerio de Salud (now Ministerio de Salud y Protección Social), 1993).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.